Alternate primers for whole-genome SARS-CoV-2 sequencing

A new study published on the preprint server bioRxiv* in October 2020 describes the gap frequencies and positions in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome and a set of alternative primers with a sequencing scheme to provide better genomic coverage and quality.

The viral RNA sequences can help decipher the transmission of the virus, its evolution in different regions, and to trace it back to the origin. Monitoring of diagnostic tests and the development of therapeutics, as well as vaccines, are also dependent on having complete and reliable sequences of the viral genome.

At present, there are over 130,000 almost complete or complete sequences of the viral genome in the GISAID database, mostly derived using targeted amplicon methods in next-generation sequencing. A glance over these genomes shows that there are many gaps across the genome, which obviously affects the quality and the interpretation of genomics studies. The current study sets forward an alternate primer set that may provide complete coverage of a high-quality genome by whole-genome sequencing.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Identifying the Issue

The researchers obtained genomes uploaded to the GISAID database in September 2020, nine months from the start of the pandemic. They looked for complete genomes and sorted the genomes using the metadata that included information on the platforms used for sequencing.

The researchers illustrated the positions of the gaps in the large genome, about 30 kb, in stretches of 200 NS each, which nearly corresponds to the size of an amplicon, in all of the first 48 genomes deposited in this month. They found that rather than being scattered at random across the genome, the gaps occur more often in certain positions.

The patterns of the gaps also showed some variation across the two platforms. This gave rise to the suspicion that the gaps left in the genome were due to unpredicted interactions between the primers, some regions of the sequence which had an unusual structure or composition, or if the primers were not correctly trimmed during the quality control process of the read data, singly or in combination.

The same patterns are observed in genomes uploaded each month, indicating the generalized nature of these gaps. However, when another platform was used, which employs an alternative set of primers, the N200 levels are much lower.

Gaps and sequencing errors continue to be reported, and towards the end of March 2020, the commonly used ARTIC primers were updated to attempt to resolve this problem. Nonetheless, well over a quarter of the genomes reported in GISAID as complete show one or more N200 gaps, as of September 2020.

Gap Analysis

The current study analyzed the gaps more closely, showing the gap pattern between nt 19,000 and 24,000 concerning the reference genome NC_045512. Every peak occurred between Forward from Amplicon X and Reverse from Amplicon X-1, but some gaps covered the whole amplified region between the primers.

This could be because the paired primers do not function properly at the amplification so that there is no amplicon for sequencing purposes. Alternatively, the original data contains amplicons sequences that are incorrectly trimmed out, perhaps, during the data analysis process, leaving a gap.

The Solution: Alternate Primers

The researchers used another set of primers to initiate amplification. This is called the Entebbe primers and adapted them with methods used earlier for the MERS-CoV, norovirus, respiratory syncytial virus (RSV), and the yellow fever virus. Particular attention was paid to the size of the amplicon and the primer positioning.

The primers were used to carry out reverse transcription, and the amplicons were multiplexed, in two alternately running sets, these steps being important for PCR. The optimal amplicon size was ~1,500 bp, since, at this size, the total content of primers was lower while the efficiency of the PCR was maintained at a high level.

The primers designed for this whole-genome sequencing were described in addition to the methods used in the laboratory to carry out reverse transcription, PCR amplification, and library preparation for the sequencing platform in use for the generation of a complete SARS-CoV-2 genome sequence.

Developing the New Process

The researchers began with all the complete sequences in the GISAID database as of June 22, 2020, coming to well over 21,500. After cleaning up the sequences by removing troublesome spaces and characters, they looked over them to remove all genomes that had gaps of 6 or more Ns. This yielded a final number of ~17,000 clean genomes.

These were cut up into strings of 33 nucleotides at a 1 nucleotide step. This generated ~600,000 unique 33mers. They then identified the 33mers that were highly conserved by counting the frequency at which they appeared, thus obviating the commonly used sequence alignment as part of the primer design process. This can become a worry if the genome sets are either large or very different.

The advantage of avoiding alignment was that all the useful genome sequences could be included, rather than just one set of sequences that allows proper alignment. The final step was to trim the sequences of 33mers, resembling primers, until they reached the defined melting temperature, meanwhile removing all primers above 26 nucleotides.

After then defining the forward and reverse bins containing the primer target regions, they selected 20 amplicons for SARS-CoV-2, which overlapped by 300 nt. These were evenly spread over the genome. Beginning with the most conserved primer sequences, they examined the mapping in the 185 nucleotides of each amplicon at the 5' or 3' ends. They also used the two primers in each bin that had the top frequency in each bin. This allowed unexpected structure-driven or target-driven alterations to be overridden to some extent. They finally came up with amplicon lengths calculated at 1495-2093 nucleotides.

They adapted the methods used for reverse transcription, PCR amplification, and library preparation to the alternative primer set.

Testing the Primers on Viral RNA

When these primers were tested on SARS-CoV-2 sequencing using material from COVID-19-positive samples on the same platform as before (MinION), they were able to map the read data, following trimming of the primers and adapters, and quality control, to the Wuhan1 reference genome NC_045512 with complete sequence coverage across the entire genome.

They showed all 20 amplicons in the coverage sequence, showing small peaks at overlapping sites, but with no missing amplicons, and easily assembled data to form complete genomes with good coverage. Alteration of the primer mixes allowed the concentrations of amplicon 1 and 16 primers to be increased for reverse transcription and PCR, with better yields compared to the other amplicons.

Implications

The authors sum up: "The current study documents the genome gap frequencies and their positions in the currently available data." The researchers also present the alternative Entebbe primers and sequencing protocol, the use of which may allow more efficient gap-less sequencing of the SARS-CoV-2 genomes, an important aspect when the cost and labor invested into this task is taken into account. This will hopefully improve the value and coverage of genomic sequencing data in the future.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Mar 29 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2023, March 29). Alternate primers for whole-genome SARS-CoV-2 sequencing. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20201014/Alternate-primers-for-whole-genome-SARS-CoV-2-sequencing.aspx.

  • MLA

    Thomas, Liji. "Alternate primers for whole-genome SARS-CoV-2 sequencing". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20201014/Alternate-primers-for-whole-genome-SARS-CoV-2-sequencing.aspx>.

  • Chicago

    Thomas, Liji. "Alternate primers for whole-genome SARS-CoV-2 sequencing". News-Medical. https://www.news-medical.net/news/20201014/Alternate-primers-for-whole-genome-SARS-CoV-2-sequencing.aspx. (accessed December 22, 2024).

  • Harvard

    Thomas, Liji. 2023. Alternate primers for whole-genome SARS-CoV-2 sequencing. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20201014/Alternate-primers-for-whole-genome-SARS-CoV-2-sequencing.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel single-cell genomics analysis approach provides direct insights into cell cycle and proliferation